Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imrecoxib for analgesia after total knee arthroplasty
ChiCTR2300072839Phase 4Recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Imrecoxib arm with Placebo arm (2 arms). Primary endpoint: Postoperative pain. Started Jun 2023; status: recruiting.
02
Drugs
imrecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2300072839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072839.